The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers
Open accessAbstract
Selective activity of a specific set of enhancers defines tissue-specific gene transcription. The pioneer factor FOXA1 has been shown to induce functional enhancer competency through chromatin openings. We have previously found that FOXA1 is recruited to thousands of regions across the genome of a given cell type. Here, we monitored the chromatin structure at FOXA1 binding sites on a chromosome-wide scale using formaldehyde assisted isolation of regulatory elements (FAIRE). Surprisingly, we find that a significant fraction of FOXA1-bound sites have a relatively closed chromatin conformation linked to a shift of the epigenetic signature toward repressive histone marks. Importantly, these sites are not correlated with gene expression in a given cell type suggesting that FOXA1 is required, but not sufficient, for the functional activity of bound enhancers. Interestingly, we find that a significant proportion of the inactive FOXA1-bound regulatory sites in one cell type are actually functional in another cellular context. We found that at least half of the FOXA1 binding sites from a given cell type are shared with another cell lineage. Mechanisms that restrict the activity of shared FOXA1-bound enhancers likely play a significant role in defining the cell-type-specific functions of FOXA1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In support of this, our data show that these loci are typically functionally inactive and not co-occupied, in agreement with previous studies (Lupien et al. 2008;Eeckhoute et al. 2009).”
From Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver (2010) · cites this paper as Eeckhoute et al. 2009
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883 · cited 1×
“…(H3K9ac), are associated with functionally competent genomic regions while meth- ylation of H3K9 (H3K9me) is related to repression (Bauer et al. 2002; Barski et al. 2007; Heintzman et al. 2007; Kouzarides 2007; Mikkelsen et al. 2007; Frietze et al. 2008; Komashko et al. 2008; Krum et al. 2008).”
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
The ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129
Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398 · cited 1×
“These domains can be identified using formaldehyde-assisted isolation of regulatory elements (FAIRE) that allows for enrichment of nucleosome-depleted genomic regions when cross-linked chromatin is subjected to phenol-chloroform extraction (Nagy et al. 2003; Hogan et al. 2006).”
BackgroundGene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,831
The complex language of chromatin regulation during transcription
Berger, S. L. (2007) · Nature · doi:10.1038/nature05915 · Cited by 2,768
Chen, X., Han, X., Yuan, P., Fang, F., Huss, M., Vega, V. B., Wong, E., Orlov, Y. L., Zhang, W., Jiang, J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.043 · Cited by 2,541
Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription
Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., & Brown, M. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00188-4 · Cited by 1,647
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1101/gr.5533506 · DOI
Cited by
Sorted by citations
Visscher, P. M., Brown, M. A., McCarthy, M. I., & Yang, J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.029 · Cited by 2,425
Self-citationPioneer transcription factors: establishing competence for gene expression
Zaret, K. S., & Carroll, J. S. (2011) · Genes & Development · doi:10.1101/gad.176826.111 · Cited by 1,589
FOXA1 is a key determinant of estrogen receptor function and endocrine response
Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D., & Carroll, J. S. (2010) · Nature Genetics · doi:10.1038/ng.730 · Cited by 864
Chromatin accessibility: a window into the genome
Tsompana, M., & Buck, M. J. (2014) · Epigenetics & Chromatin · doi:10.1186/1756-8935-7-33 · Cited by 473
Arnal, J., Lenfant, F., Métivier, R., Flouriot, G., Henrion, D., Adlanmérini, M., Fontaine, C., Gourdy, P., Chambon, P., Katzenellenbogen, B. S., et al. (2017) · Physiological Reviews · doi:10.1152/physrev.00024.2016 · Cited by 453
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Ni, M., Chen, Y., Lim, E., Wimberly, H., Bailey, S. T., Imai, Y., Rimm, D. L., Liu, X. S., & Brown, M. A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.026 · Cited by 401
Self-citationSahu, B., Laakso, M., Ovaska, K., Mirtti, T. K., Lundin, J. E., Rannikko, A. S., Sankila, A., Turunen, J.-P., Lundin, M., Konsti, J., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.328 · Cited by 399
Mechanisms of enhancer action: the known and the unknown
Panigrahi, A., & O’Malley, B. W. (2021) · Genome biology · doi:10.1186/s13059-021-02322-1 · Cited by 376
Siersbæk, R., Nielsen, R., John, S., Sung, M., Baek, S., Loft, A., Hager, G. L., & Mandrup, S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.65 · Cited by 350
Simon, J. M., Giresi, P. G., Davis, I. J., & Lieb, J. D. (2012) · Nature Protocols · doi:10.1038/nprot.2011.444 · Cited by 324
Toska, E., Osmanbeyoglu, H. U., Castel, P., Chan, C., Hendrickson, R. C., Elkabets, M., Dickler, M. N., Scaltriti, M., Leslie, C. S., Armstrong, S. A., et al. (2017) · Science · doi:10.1126/science.aah6893 · Cited by 269
Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancersPreprint
Sérandour, A. A., Avner, S., Percevault, F., Demay, F., Bizot, M., Lucchetti-Miganeh, C., Barloy-Hubler, F., Brown, M. A., Lupien, M., Métivier, R., et al. (2011) · Genome Research · doi:10.1101/gr.111534.110 · Cited by 248
Self-citationFOXA1: a transcription factor with parallel functions in development and cancer
Bernardo, G. M., & Keri, R. A. (2011) · Bioscience Reports · doi:10.1042/bsr20110046 · Cited by 236
Fu, J., Wolfs, M. G. M., Deelen, P., Westra, H.-J., Fehrmann, R. S. N., Meerman, G. J. T., Buurman, W. A., Rensen, S. S., Groen, H. J. M., Weersma, R. K., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002431 · Cited by 218
Predictive chromatin signatures in the mammalian genome
Hon, G. C., Hawkins, R. D., & Ren, B. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp409 · Cited by 231
Lefterova, M. I., Steger, D. J., Zhuo, D. X., Qatanani, M., Mullican, S. E., Tuteja, G., Manduchi, E., Grant, G. R., & Lazar, M. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01651-09 · Cited by 213
Kong, S. L., Li, G., Loh, S. L., Sung, W.-K. K., & Liu, E. T. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.59 · Cited by 205
The FoxA factors in organogenesis and differentiation
Kaestner, K. H. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.06.005 · Cited by 202
PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer
Magnani, L., Ballantyne, E. B., Zhang, X., & Lupien, M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002368 · Cited by 198
Self-citationDynamic hydroxymethylation of deoxyribonucleic acid marks differentiation-associated enhancers
Sérandour, A. A., Avner, S., Oger, F., Bizot, M., Percevault, F., Lucchetti-Miganeh, C., Palierne, G., Gheeraert, C., Barloy-Hubler, F., Péron, C. L., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks595 · Cited by 199
Self-citationMagnani, L., Stoeck, A., Zhang, X., Lánczky, A., Mirabella, A., Wang, T., Győrffy, B., & Lupien, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219992110 · Cited by 187
Self-citationLupien, M., Meyer, C. A., Bailey, S. T., Eeckhoute, J., Cook, J., Westerling, T., Zhang, X., Carroll, J. S., Rhodes, D. R., Liu, X., et al. (2010) · Genes & Development · doi:10.1101/gad.1944810 · Cited by 171
Self-citationPioneer factors: directing transcriptional regulators within the chromatin environment
Magnani, L., Eeckhoute, J., & Lupien, M. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.07.002 · Cited by 173
Self-citationSelective amputation of the pharynx identifies a FoxA-dependent regeneration program in planaria
Adler, C. E., Seidel, C. W., McKinney, S., & Alvarado, A. S. (2014) · eLife · doi:10.7554/elife.02238 · Cited by 160
AP‐2γ regulates oestrogen receptor‐mediated long‐range chromatin interaction and gene transcription
Tan, S. K., Lin, Z. H., Chang, C. W., Varang, V., Chng, K. R., Pan, Y. F., Yong, E., Sung, W.-K. K., & Cheung, E. C. W. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.151 · Cited by 156
Pham, T.-H., Benner, C., Lichtinger, M., Schwarzfischer, L., Hu, Y., Andreesen, R., Chen, W., & Rehli, M. (2012) · Blood · doi:10.1182/blood-2012-01-402453 · Cited by 143
Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling
Pihlajamaa, P., Sahu, B., & Jänne, O. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1034 · Cited by 144
FOXA1 is an independent prognostic marker for ER-positive breast cancer
Mehta, R. J., Jain, R., Leung, S. C. Y., Choo, J. R., Nielsen, T. O., Huntsman, D. D., Nakshatri, H., & Badve, S. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1482-6 · Cited by 127
Chromatin signatures of active enhancers
Spicuglia, S., & Vanhille, L. (2012) · Nucleus · doi:10.4161/nucl.19232 · Cited by 127
Hoffman, B. G., Robertson, G., Zavaglia, B., Beach, M., Cullum, R., Lee, S., Soukhatcheva, G., Li, L., Wederell, E. D., Thiessen, N., et al. (2010) · Genome Research · doi:10.1101/gr.104356.109 · Cited by 115
“Secondary co-occupying transcription factors ensure nucleosome displacement Previously, it was shown that differential recruitment of ESR1 and AR in breast and prostate cancer cell lines, respectively, correlates with the accessibility and functionality of FOXA1 sites (Eeckhoute et al. 2009).”
BackgroundResultBoudot, A. J., Kerdivel, G., Habauzit, D., Eeckhoute, J., Dily, F. L., Flouriot, G., Samson, M., & Pakdel, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020898 · Cited by 113
Self-citationMechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1
Pham, T.-H., Minderjahn, J., Schmidl, C., Hoffmeister, H., Schmidhofer, S., Chen, W., Längst, G., Benner, C., & Rehli, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt355 · Cited by 102
Aberrant Estrogen Regulation of PEMT Results in Choline Deficiency-associated Liver Dysfunction
Resseguie, M., da Costa, K.-A., Galanko, J. A., Patel, M., Davis, I. J., & Zeisel, S. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.106922 · Cited by 104
Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation
Antignano, F., Burrows, K., Hughes, M. R., Han, J. M., Kron, K. J., Penrod, N. M., Oudhoff, M. J., Wang, S. K. H., Min, P. H., Gold, M. J., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69592 · Cited by 104
Self-citationAndrogen receptor genomic regulation.
Jin, H., Kim, J., & Yu, J. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-4683.2013.09.01 · Cited by 103
Svotelis, A., Bianco, S., Madore, J., Huppé, G., Nordell-Markovits, A., Mes‐Masson, A., & Gévry, N. Y. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.284 · Cited by 98
Zhang, C., Wang, L., Wu, D., Chen, H., Chen, Z., Thomas‐Ahner, J. M., Zynger, D. L., Eeckhoute, J., Yu, J., Luo, J., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1882 · Cited by 93
Self-citationThe Chromatin Fingerprint of Gene Enhancer Elements
Zentner, G. E., & Scacheri, P. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.296491 · Cited by 92
Zhang, Z., Yang, C., Gao, W., Chen, T., Qian, T., Hu, J. X., & Tan, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.008 · Cited by 87
Amplitude modulation of androgen signaling by c-MYCPreprint
Ni, M., Chen, Y., Fei, T., Li, D., Lim, E., Liu, X. S., & Brown, M. A. (2013) · Genes & Development · doi:10.1101/gad.209569.112 · Cited by 88
Self-citationMolecular basis for gene-specific transactivation by nuclear receptors
Aagaard, M. M., Siersbæk, R., & Mandrup, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.018 · Cited by 93
FoxA1 is a Key Mediator of Hormonal Response in Breast and Prostate Cancer
Robinson, J. L. L., & Carroll, J. S. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00068 · Cited by 85
Cistromics of hormone-dependent cancer
Lupien, M., & Brown, M. A. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0038 · Cited by 84
Self-citationCurrent perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer
Yang, Y. A., & Yu, J. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.01.003 · Cited by 84
Sulahian, R., Casey, F., Shen, J., Qian, Z., Shin, H., Ogino, S., Weir, B. A., Vázquez, F., Liu, X. S., Hahn, W. C., et al. (2013) · Oncogene · doi:10.1038/onc.2013.517 · Cited by 78
Self-citationEpigenetic pioneering by SWI/SNF family remodelers
Ahmad, K., Brahma, S., & Henikoff, S. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.045 · Cited by 77
Coactivator Function Defines the Active Estrogen Receptor Alpha Cistrome
Lupien, M., Eeckhoute, J., Meyer, C. A., Krum, S. A., Rhodes, D. R., Liu, X., & Brown, M. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00020-09 · Cited by 76
Self-citationBerchowitz, L. E., Hanlon, S. L., Lieb, J. D., & Copenhaver, G. P. (2009) · Genome Research · doi:10.1101/gr.096297.109 · Cited by 72
Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer
Zhou, S., Hawley, J. R., Soares, F., Grillo, G., Teng, M., Tonekaboni, S. A. M., Hua, J. T., Kron, K. J., Mazrooei, P., Ahmed, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14318-9 · Cited by 69
Self-citationChromatin and epigenetic determinants of estrogen receptor alpha (ESR1) signaling
Magnani, L., & Lupien, M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.026 · Cited by 67
Self-citationThe Forkhead Transcription Factor FOXK2 Promotes AP-1-Mediated Transcriptional Regulation
Ji, Z., Donaldson, I. J., Liu, J., Hayes, A., Zeef, L. A. H., & Sharrocks, A. D. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05504-11 · Cited by 62
Minireview: Pioneer Transcription Factors in Cell Fate Specification
Drouin, J. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1084 · Cited by 51
Cross-regulation between FOXA1 and ErbB2 Signaling in Estrogen Receptor-Negative Breast Cancer
Naderi, A., Meyer, M., & Dowhan, D. H. (2012) · Neoplasia · doi:10.1593/neo.12294 · Cited by 54
Holmes, K. A., Hurtado, A., Brown, G. D., Launchbury, R., Ross-Innes, C. S., Hadfield, J., Odom, D. T., & Carroll, J. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018863108 · Cited by 50
Kerschner, J. L., Gosalia, N., Leir, S., & Harris, A. (2014) · Epigenetics · doi:10.4161/epi.27696 · Cited by 54
Organ-specific gene expression: the bHLH protein Sage provides tissue specificity toDrosophilaFoxA
Fox, R. M., Vaishnavi, A., Maruyama, R., & Andrew, D. J. (2013) · Development · doi:10.1242/dev.092924 · Cited by 44
Eeckhoute, J., Oger, F., Staels, B., & Lefèbvre, P. (2012) · PPAR Research · doi:10.1155/2012/164140 · Cited by 45
Self-citationWarrick, J. I., Hu, W., Yamashita, H., Walter, V., Shuman, L., Craig, J. M., Gellert, L. L., Castro, M. A. A., Robertson, A. G., Kuo, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34251-3 · Cited by 44
Traboulsi, T., Ezzy, M. E., Dumeaux, V., Audemard, E. O., & Mader, S. (2018) · Oncogene · doi:10.1038/s41388-018-0468-9 · Cited by 44
Cytosine modifications modulate the chromatin architecture of transcriptional enhancersPreprint
Mahé, E. A., Madigou, T., Sérandour, A. A., Bizot, M., Avner, S., Chalmel, F., Palierne, G., Métivier, R., & Salbert, G. (2017) · Genome Research · doi:10.1101/gr.211466.116 · Cited by 46
Emerging patterns of epigenomic variation
Milosavljevic, A. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.03.001 · Cited by 39
Noncoding deletions reveal a gene that is critical for intestinal function
Oz-Levi, D., Olender, T., Bar-Joseph, I., Zhu, Y., Marek‐Yagel, D., Barozzi, I., Osterwalder, M., Alkelai, A., Ruzzo, E. K., Han, Y., et al. (2019) · Nature · doi:10.1038/s41586-019-1312-2 · Cited by 39
A Detailed Protocol for Formaldehyde‐Assisted Isolation of Regulatory Elements (FAIRE)
Simon, J. M., Giresi, P. G., Davis, I. J., & Lieb, J. D. (2013) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb2126s102 · Cited by 37
Analysis of Chromatin Dynamics during Glucocorticoid Receptor Activation
Burd, C. J., Ward, J. M., Crusselle‐Davis, V. J., Kissling, G. E., Phadke, D. P., Shah, R., & Archer, T. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06206-11 · Cited by 36
FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women?
Espinal, A. C., Buas, M. F., Wang, D., Cheng, D. T.-Y., Sucheston‐Campbell, L. E., Hu, Q., Yan, L., Ondracek, R. P., Cortes, E., Tang, L., et al. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4418-y · Cited by 36
Lennartsson, A., Arner, E., Fagiolini, M., Saxena, A., Andersson, R., Takahashi, H., Noro, Y., Sng, J., Sandelin, A., Hensch, T. K., et al. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0043-3 · Cited by 37
Boudot, A. J., Kerdivel, G., Lecomte, S., Flouriot, G., Desille, M., Godey, F., Lévêque, J., Tas, P., Dréan, Y. L., & Pakdel, F. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-407 · Cited by 34
Histone signature of metanephric mesenchyme cell lines
McLaughlin, N., Yao, X., Li, Y., Saifudeen, Z. R., & El-Dahr, S. S. (2013) · Epigenetics · doi:10.4161/epi.25753 · Cited by 30
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
Nardone, A., Qiu, X., Spisák, S., Nagy, Z., Feiglin, A., Feit, A. S., Feit, G. C., Xie, Y., Font‐Tello, A., Guarducci, C., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3186 · Cited by 29
Lo, R., Celius, T., Karmaus, A. L., Dere, E., MacPherson, L., Harper, P. A., Zacharewski, T. R., & Matthews, J. B. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.08.016 · Cited by 28
Defining specificity of transcription factor regulatory activities
Eeckhoute, J., Métivier, R., & Salbert, G. (2009) · Journal of Cell Science · doi:10.1242/jcs.054916 · Cited by 26
Self-citationGenome-wide interplay of nuclear receptors with the epigenome
Martens, J. H. A., Rao, N., & Stunnenberg, H. G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.10.005 · Cited by 28
Maruyama, R., Grevengoed, E. E., STEMPNIEWICZ, P., & Andrew, D. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020901 · Cited by 23
Pascual-Carreras, E., Herrera-Úbeda, C., Rosselló, M., Coronel-Córdoba, P., García‐Fernàndez, J., Saló, E., & Adell, T. (2021) · Scientific Reports · doi:10.1038/s41598-020-80627-0 · Cited by 24
Characterization of Chromatin Structure-associated Histone Modifications in Breast Cancer Cells
Hong, C. P., Choe, M. K., & Roh, T. (2012) · Genomics & Informatics · doi:10.5808/gi.2012.10.3.145 · Cited by 21
Transcription Factor Interactions in Genomic Nuclear Receptor Function
George, C. L., Lightman, S. L., & Biddie, S. C. (2011) · Epigenomics · doi:10.2217/epi.11.66 · Cited by 21
Chen, T., He, S., Zhang, Z., Gao, W., Li, Y., & Tan, Y. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.04.020 · Cited by 20
Chromatin Landscape and Endocrine Response in Breast Cancer
Magnani, L., Brunelle, M., Gévry, N. Y., & Lupien, M. (2012) · Epigenomics · doi:10.2217/epi.12.64 · Cited by 17
Self-citationInterrogating genomic and epigenomic data to understand prostate cancer
Kim, J., & Yu, J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.12.003 · Cited by 16
Mapping Open Chromatin with Formaldehyde-Assisted Isolation of Regulatory Elements
Nammo, T., Rodríguez‐Seguí, S. A., & Ferrer, J. P. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-316-5_21 · Cited by 14
Differential Glucocorticoid Receptor-mediated Transcription Mechanisms
Aoyagi, S., & Archer, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.195040 · Cited by 13
Ovesen, J. L., Fan, Y., Zhang, X., Chen, J., Medvedovic, M., Xia, Y., & Puga, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097849 · Cited by 13
Lai, Y.-R., Lu, Y., Lien, H.-W., Huang, C., & Hwang, S. L. (2016) · Biochemical Journal · doi:10.1042/bcj20160392 · Cited by 13
Crosstalk and DC-SCRIPT: Expanding nuclear receptor modulation
Ansems, M., Hontelez, S., Karthaus, N., Span, P. N., & Adema, G. J. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.05.001 · Cited by 12
Cistrome plasticity and mechanisms of cistrome reprogramming
García-Bassets, I., & Wang, D. (2012) · Cell Cycle · doi:10.4161/cc.21281 · Cited by 11
Arora, S., Yang, J., Akiyama, T., James, D. Q., Morrissey, A., Blanda, T. R., Badjatia, N., Lai, W., Ko, M. S. H., Pugh, B. F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.06.561228 · Cited by 8
Xia, K., Huang, W., Zhao, X., Huang, X., Chen, Y., Li, Y., & Tan, Y. (2022) · PubMed Central · Cited by 7
Kneppers, J., Bergman, A. M., & Zwart, W. T. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11836-4_15 · Cited by 6
The role of FOXA subfamily factors in embryonic development and carcinogenesis of the pancreas
Zinovyeva, M. V., Kuzmich, A. I., MONASTYRSKAYA, G. S., & Sverdlov, E. D. (2016) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416816030113 · Cited by 6
Zinovyeva, M. V., Kuzmich, A. I., MONASTYRSKAYA, G. S., & Sverdlov, E. D. (2016) · Molecular Genetics Microbiology and Virology (Russian) · doi:10.18821/0208-0613-2016-34-3-98-103 · Cited by 5
Simon, J. M., Giresi, P. G., Davis, I. J., & Lieb, J. D. (2014) · Nature Protocols · doi:10.1038/nprot.2014.062 · Cited by 4
Chromatin Variants Reveal the Genetic Determinants of Oncogenesis in Breast CancerPreprint
Bahl, S., Carroll, J. S., & Lupien, M. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041322 · Cited by 4
Self-citationGilfillan, S., Wang, S., Katika, M. R., Norum, J. H., Bergholtz, H., Fiorito, E., Nordhagen, S., Sharma, Y., Singh, S. K., Somisety, V. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.22.308569 · Cited by 1
Tipping the Balance: Factors That Influence the ER Signaling Network in Breast Cancer
Jasper, J. S. (2014) · DukeSpace (Duke University)
Magnani, L., Louloupi, A., & Zwart, W. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801899-6.00023-1
Discerning the role of FOXA1 in mammary gland development and breast cancer
Bernardo, G. M. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Identifying FoxA1 interacting partners : insight into androgen regulated prostatic genes.
Sun, Q. (2010) · Europe PMC (PubMed Central)
FOXA1 is an independent prognostic marker for ER-positive breast cancer
Tudy, P. S. (2012)
A novel DNA sequence motif in human and mouse genomes
Zhang, S., Du, F., & Ji, H. (2015) · Scientific Reports · doi:10.1038/srep10444
Twenty-First Century Glucocorticoid Receptor Molecular Biology
Wang, C., Oldenkamp, R., Oellers, R., & Logie, C. (2018) · InTech eBooks · doi:10.5772/intechopen.72016
Metadata
- Authors
- Eeckhoute, J., Lupien, M., Meyer, C. A., Verzi, M. P., Shivdasani, R. A., Liu, X. S., & Brown, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- ORCID
- Venue
- Genome Research
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2009-01-07
- Volume
- 19
- Issue
- 3
- Pages
- 372-380
- ISSN
- 1088-9051 (ISSN-L)
- PMC
- PMC2661808
- OpenAlex
- W2147789776
- Cited by
- 106
- References
- 63
- Citations by year
- 2026: 1 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 10 · 2013: 9 · 2012: 16
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genome Research (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- HAL (submittedVersion)
- Funders
- Dana-Farber Cancer Institute
- Dana-Farber/Harvard Cancer Center
- Centre National de la Recherche Scientifique
- National Human Genome Research Institute (R01HG004069)
- National Cancer Institute (P01CA8011105)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK074967)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- FOXA1, enhancers, chromatin remodeling, cell type specificity, FAIRE, chromatin accessibility, histone modifications, pioneer factors
- MeSH terms
- Binding Sites, Chromosome Mapping, Enhancer Elements, Genetic, Humans, Organ Specificity, Protein Binding, Tumor Cells, Cultured, Transcriptional Activation, Conserved Sequence, Cell Lineage, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Chromatin Assembly and Disassembly, Hepatocyte Nuclear Factor 3-alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
